{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T14:05:32Z","timestamp":1795097132110,"version":"4.10.3"},"reference-count":13,"publisher":"American Society of Hematology","issue":"13","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Autoimmune lymphoproliferative syndrome (ALPS) is characterized by chronic nonmalignant lymphadenopathy, splenomegaly, cytopenias, and other autoimmune manifestations. ALPS is caused by lymphocyte accumulation from defects in FAS-mediated apoptosis. Heterozygous germline or somatic pathogenic single nucleotide variants in FAS are the most common molecular etiology of ALPS. Through the Centralized Sequencing Program at the National Institute of Allergy and Infectious Diseases, we performed exome sequencing on subjects with a clinical diagnosis of ALPS, with a subset receiving copy number variant (CNV) analysis. In this cohort, we identified 3 subjects from unrelated families with CNVs at the FAS locus. One subject had a de novo \u223c0.828 Mb copy number loss encompassing all of FAS. The second subject had a maternally inherited \u223c1.004 Mb copy number loss encompassing all of FAS. The third subject had a paternally inherited \u223c0.044 Mb copy number loss encompassing exons 7 through 9 of FAS. Subjects with deletions in FAS had clinical presentations and biomarker profiles similar to those with ALPS and with germline and somatic FAS variants. We demonstrate that CNV analysis should be pursued if there is clinical and biomarker evidence of ALPS because it can lead to a molecular diagnosis and appropriate treatment when FAS sequencing is inconclusive.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021005835","type":"journal-article","created":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T14:13:16Z","timestamp":1651068796000},"page":"3974-3978","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":11,"title":["The contribution of rare copy number variants in <i>FAS<\/i> toward pathogenesis of autoimmune lymphoproliferative syndrome"],"prefix":"10.1182","volume":"6","author":[{"given":"Kathleen","family":"Jevtich","sequence":"first","affiliation":[{"name":"1National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Price","sequence":"additional","affiliation":[{"name":"1National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Similuk","sequence":"additional","affiliation":[{"name":"1National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Kulm","sequence":"additional","affiliation":[{"name":"2Clinical Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0506-5957","authenticated-orcid":false,"given":"Jia","family":"Yan","sequence":"additional","affiliation":[{"name":"1National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Setzer","sequence":"additional","affiliation":[{"name":"1National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1132-2411","authenticated-orcid":false,"given":"Leila","family":"Jamal","sequence":"additional","affiliation":[{"name":"3NIH Clinical Center Department of Bioethics, National Institutes of Health, Bethesda, MD; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0540-5942","authenticated-orcid":false,"given":"Luis M.","family":"Franco","sequence":"additional","affiliation":[{"name":"4National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajarshi","family":"Ghosh","sequence":"additional","affiliation":[{"name":"1National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Walkiewicz","sequence":"additional","affiliation":[{"name":"1National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7881-6902","authenticated-orcid":false,"given":"V. Koneti","family":"Rao","sequence":"additional","affiliation":[{"name":"1National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2022,7,7]]},"reference":[{"issue":"13","key":"2022070715214618100_B1","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1182\/blood-2013-10-535393","article-title":"Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations","volume":"123","author":"Price","year":"2014","journal-title":"Blood."},{"issue":"1","key":"2022070715214618100_B2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/gim.0b013e3182310b7d","article-title":"Autoimmune lymphoproliferative syndrome due to FAS mutations outside the signal-transducing death domain: molecular mechanisms and clinical penetrance","volume":"14","author":"Hsu","year":"2012","journal-title":"Genet Med."},{"issue":"5","key":"2022070715214618100_B3","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s10875-018-0523-x","article-title":"The autoimmune lymphoproliferative syndrome with defective FAS or FAS-ligand functions","volume":"38","author":"Rieux-Laucat","year":"2018","journal-title":"J Clin Immunol."},{"issue":"4","key":"2022070715214618100_B4","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1086\/302333","article-title":"Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance","volume":"64","author":"Jackson","year":"1999","journal-title":"Am J Hum Genet."},{"issue":"5215","key":"2022070715214618100_B5","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1126\/science.7539157","article-title":"Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity","volume":"268","author":"Rieux-Laucat","year":"1995","journal-title":"Science."},{"issue":"9029","key":"2022070715214618100_B6","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0140-6736(96)02293-3","article-title":"Clinical, immunological, and pathological consequences of Fas-deficient conditions","volume":"348","author":"Le Deist","year":"1996","journal-title":"Lancet."},{"issue":"2","key":"2022070715214618100_B7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/intimm\/10.2.195","article-title":"Novel Fas (CD95\/APO-1) mutations in infants with a lymphoproliferative disorder","volume":"10","author":"Kasahara","year":"1998","journal-title":"Int Immunol."},{"issue":"10","key":"2022070715214618100_B8","doi-asserted-by":"crossref","first-page":"6035","DOI":"10.4049\/jimmunol.1100021","article-title":"FAS haploinsufficiency is a common disease mechanism in the human autoimmune lymphoproliferative syndrome","volume":"186","author":"Kuehn","year":"2011","journal-title":"J Immunol."},{"issue":"6","key":"2022070715214618100_B9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/humu.10212","article-title":"Human Gene Mutation Database (HGMD): 2003 update","volume":"21","author":"Stenson","year":"2003","journal-title":"Hum Mutat."},{"issue":"2","key":"2022070715214618100_B10","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1046\/j.1365-2141.1998.00791.x","article-title":"The use of the anti-malaria drug Fansidar (pyrimethamine and sulphadoxine) in the treatment of a patient with autoimmune lymphoproliferative syndrome and Fas deficiency","volume":"102","author":"van der Werff ten Bosch","year":"1998","journal-title":"Br J Haematol."},{"issue":"1","key":"2022070715214618100_B11","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1172\/JCI43752","article-title":"Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation","volume":"121","author":"Mag\u00e9rus-Chatinet","year":"2011","journal-title":"J Clin Invest."},{"key":"2022070715214618100_B12","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1145\/3233547.3233641","volume-title":"Proceedings of the 2018 ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics","author":"Veltri","year":"2018"},{"issue":"25","key":"2022070715214618100_B13","doi-asserted-by":"crossref","first-page":"5164","DOI":"10.1182\/blood-2010-01-263145","article-title":"Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome","volume":"115","author":"Dowdell","year":"2010","journal-title":"Blood."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/13\/3974\/1905764\/advancesadv2021005835.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/13\/3974\/1905764\/advancesadv2021005835.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T15:22:07Z","timestamp":1657207327000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/13\/3974\/485071\/The-contribution-of-rare-copy-number-variants-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,7]]},"references-count":13,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2022,7,12]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021005835","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,7]]}}}